Sign Up Today and Learn More About Canton Biologics Stock
Invest in or calculate the value of your shares in Canton Biologics or other pre-IPO companies through EquityZen's platform.
Canton Biologics Stock (CATB)
Canton Biologics is a biologics contract development and manufacturing outsourcing company.
About Canton Biologics Stock
Founded
2016
Industries
Manufacturing, Professional Services, Science and Engineering
Canton Biologics Press Mentions
Stay in the know about the latest news on Canton Biologics
Gemdale Viseen Life Science Theme Industrial Park Strategy ...
prnewswire • Dec 20, 2023
Week In Review: Everest Acquires Novel Autoimmune ...
seekingalpha • Dec 20, 2023
CDMOs Nephron and Canton each raise hundreds of millions ...
endpts • Dec 20, 2023
Canton Biologics Completes Over 300M Yuan Series C Financing
finsmes • Sep 19, 2023
Canton Biologics Raises $41 Million in C Round for Biologic CDMO Services
chinabiotoday • Sep 19, 2023
Canton Biologics Management
Leadership team at Canton Biologics
Founder & CEO
Dr. Xiao Shen
Join now and verify your accreditation status to gain access to:
- Canton Biologics current valuation
- Canton Biologics stock price
- Available deals in Canton Biologics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Canton Biologics Stock
How to invest in Canton Biologics stock?
Accredited investors can buy pre-IPO stock in companies like Canton Biologics through EquityZen funds. These investments are made available by existing Canton Biologics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Canton Biologics stock?
Shareholders can sell their Canton Biologics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
